Your Path to Hope Resources

Kansas City beneficiary partners, the University of Kansas Cancer Center and Children’s Mercy, collaborated in efforts to treat a pediatric brain tumor patient.

In the relentless battle against cancer, advancements in personalized medicine are shaping a new frontier of hope and resilience.

In the age of digital connectivity and social media, the internet has become an invaluable tool for providing support and staying connected, especially for patients and their caregivers.

Brain cancer is a devastating diagnosis that profoundly affects patients and their families. The treatment of brain cancer typically involves a combination of surgery, chemotherapy, and radiation therapy. While these treatments are crucial for combating cancer, they often come with a host of physical and emotional side effects. Myofascial release therapy is emerging as a complementary approach that can provide significant benefits to brain cancer patients, helping them manage symptoms, improve their quality of life, and support their overall well-being.

A $2.8 million grant from the National Cancer Institute will help researchers overcome challenges in using engineered T cells to treat glioblastoma.

Gift from a Child is a national initiative supported by families who have lost children to brain cancer, private foundations, researchers and medical professionals. It currently receives its funding from the Swifty Foundation.

Head for the Cure and Brains for the Cure is proud to partner with world-renowned hospitals and organizations across the country as beneficiary partners for Head for the Cure’s 5K run/walks.

I was able to attend The Society of Neuro-Oncology annual meeting in November 2022 and learned an amazing amount about what the field is focusing on and how it can pave the way for future treatments of this horrible disease.

DJ utilized the innovative Tumor-Treating Fields technology by wearing the Optune device for 2 years. Last year, DJ joined the Head for the Cure staff as its Community Outreach Coordinator.

For the first time in 12 years, glioblastoma patients in Canada have a new treatment option.